So I'm a sophomore at a target school. I am trying to decide if I should recruit for M&A or RX for my junior year summer internship. Any thoughts or advice? Would love to learn about how interesting the work is, exit opportunities (HF, PE), and how much I can learn through the experience. Thanks a lot!
| +201 | Why UBS Is the Worst Place to Start Your IB Career | 34 | 4h |
| +160 | ONLY THESE BANKS OR YOU STRUCK OUT | 41 | 9m |
| +65 | Firm Thinks I'm Lying About Offer | 20 | 22h |
| +59 | Indiana University Fraternity Pipelines | 35 | 15h |
| +50 | Rogo AI | 20 | 12h |
| +42 | Suspended for a Year | 19 | 7h |
| +41 | Elite Boutique interview questions | 10 | 11h |
| +39 | Stay at Weak Dealflow Team or Lateral? | 12 | 1d |
| +26 | UBS 2nd Year Analyst Q&A (2026) | 12 | 1h |
| +23 | 1st Half 2026 (1H26) RX IB & RX Co. Rankings | 16 | 9h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Rx is a no-brainer if you want to do distressed HF/PE.
Rx is still a better option overall if you get into a place like PJT, HL, LAZ, EVR, Moelis, Gugg, Greenhill, PWP, etc. since you can pretty easily exit to vanilla PE as well, especially from a generalist program.
??? Except PJT/HL and maybe Lazard I’m taking M&A over restructuring for all the other shops you mentioned.
is EVR RX not on par with HL and LAZ?
what about Rothschild RX
Not a really great group anymore from what I've heard. Lost a ton of senior management in the last half decade to a few places, recently to TRS Advisors, and the brand name outside of Europe has been diminishing along with them.
Gugg and GHL are kind of an L compared to the others. Also I havent heard great things about PWP rx. The others are fire though
I would say Rx provides more optionality (with respect to PE & HF) in the sense that they get looks from HF a bit more than M&A, whereas PE looks are roughly comparable between M&A/Rx. That being said, groups like EVR M&A still get a ton of HF looks.
In general, Rx leans more HF exits and M&A leans more PE exits.
How does a place like Ducera or Miller Buckfire compare to the aforementioned Rx groups?
.
Below Rothschild? And what would they be better/worse for after 2yrs
how is working on M&A deals vs RX deals?
Accusantium ipsa ut est. Quisquam placeat delectus minus quas consequatur. Corrupti minima laboriosam ea voluptatum atque. Excepturi rerum ex sint veniam.
Labore beatae rerum quis voluptas magni neque. Non ab consequatur numquam et quo totam. Nulla tenetur animi consequatur aut aliquam officia distinctio. Sit voluptas rerum officia esse consequuntur ducimus quibusdam. Assumenda vero ut repellat officiis omnis tenetur totam.
Dicta sunt exercitationem eligendi impedit vel. Deserunt modi cupiditate cupiditate ullam nulla nostrum. Impedit enim qui voluptatem dicta quas consequuntur eum deserunt. Eum iusto vel nemo eum a. Autem quia ex quasi quia. Quasi vero suscipit et vitae sit nesciunt.
Nobis qui cum dignissimos. Sed et rem doloribus doloremque veritatis rem. Incidunt possimus quibusdam veniam eos provident omnis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...